The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe. One of the world’s most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. News & World Report for more than 30 years.
Vaccination for COVID-19 and Influenza (flu) is mandatory for all MSK staff. Staff are considered fully vaccinated upon completion of a primary vaccination series for COVID-19 (i.e., one dose of a single dose vaccine or a final dose of a multi-dose vaccine series). Exceptions from the COVID-19 and Influenza (flu) vaccine requirements are permitted for those who request and receive an approved medical, religious, or fully remote exemption. Requests for exemption can take up to two weeks to review. Vaccination or an approved exemption is required to start work.
Job DescriptionThe Kung Lab is seeking a highly motivated and successful individual who should be highly proficient in a variety of molecular and cellular biology techniques and have a strong fundamental knowledge of cancer genetics and epigenetics. Candidates with experience in cellular therapy development (e.g., CAR-T, BiTE, TCR) is highly desired. Experience with next generation sequencing (WGS, RNAseq, ChIP-seq), gene editing (CRISPR), and/or mouse cancer models (transgenic or xenograft models) are also desired. The candidate will lead the development and evaluation of cell therapy-based approaches with the goal of translating promising constructs into the clinic for the treatment of pediatric cancer.
The laboratory headed by Dr. Andrew Kung, located in the Mortimer B. Zuckerman Research Center, focuses on translational research with the overarching goal of credentialing new therapeutic targets, identifying molecular biomarkers of response, and validating targeted therapeutic strategies for pediatric malignancies. https://www.mskcc.org/research-areas/labs/andrew-kung
The ideal candidate should have:
PhD or MD/PhD Strong publication record, including first author peer-reviewed publications Prior cancer biology research experience Excellent communication and writing skills.
If you have any questions about this job opportunity, please contact:
Nydia Toribio
toribion@mskcc.org
Please include a cover letter, brief statement of prior research experience and research interests, CV, and contact information for three references in your application submission.
Salary: $74,263 - $85,402
#LI-Onsite#LI-Onsite ClosingMSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.
Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.
Stay in touch! Register now to join Memorial Sloan Kettering’s Talent Community to receive inside information on our organization and new job opportunities.